VISIONFLEX GROUP LIMITED — Interim / Quarterly Report 2026

Jan 22, 2026

ASX Announcement – 23 January 2026 Visionflex Group Limited (ASX:VFX)

==> picture [595 x 8] intentionally omitted <==

==> picture [155 x 23] intentionally omitted <==

Q2 FY26 Quarterly Activity Report

Highlights:

• Cash receipts of $1m, up 22% on the pcp

• Operating cash outflow of $0.3m, improved from $0.5m outflow in the pcp

• Unaudited revenue of $0.8m , down 12% on the pcp

• Annual Recurring Revenue of $1.95m at the end of Q2 FY26, up 23% on the pcp

• Share consolidation completed on a 50:1 basis

• Continued progress across key enterprise and government customers

Visionflex Group Limited (“ VFX ” or the “ Company ”), a leader in virtual healthcare technology, provides its Appendix 4C and quarterly market update for the 3 months ending 31 December 2025.

Visionflex CEO & Managing Director, Joshua Mundey commented: “Q2 delivered continued customer validation across our core markets. The renewal of RFDS Victoria for a second year, alongside constructive discussions underway in other RFDS jurisdictions, reinforces the relevance of our platform in complex, distributed care environments.

We also maintained momentum in residential aged care, with Amplar Health progressing deployments across multiple facilities. As we advance strategic partnerships and integration pathways to support scale and broader adoption, I expect these initiatives to contribute to revenue growth in the second half of FY26.”

Financial Performance – Q2 FY26

Customer cash receipts totalled $1.0 million, representing a 22% increase on the pcp.

The operating cash outflow was $0.3 million, an improvement from the $0.5 million outflow in the pcp, driven by tighter cost control and a higher proportion of recurring revenue.

Operating and administration payments were $1.8 million, in line with the pcp.

Unaudited revenue was $0.8 million, down 12% on the pcp. Approximately 55% of quarterly revenue was recurring, reflecting lower hardware sales and an increasing contribution from higher-margin software revenue.

ARR was $1.95 million, up 23% on the pcp. ARR was down 1% on Q1 FY26, primarily due to the conclusion of the Siemens’ three-year trial. Excluding Siemens, ARR would have increased 31% on pcp and 6% on Q1 FY26, reflecting underlying growth across the core customer base.

As at 31 December 2025, the Company held $1.1 million of cash, with a further $1 million available under its existing debt facility with cornerstone investor, Adcock Private Equity.

Remuneration for Mr Mundey and Mr Kafrouni in their executive roles and Mr Adcock in his role as a Director has been disclosed as related party transactions in the Appendix 4C.

Visionflex Group Limited ACN 138 897 533 Unit 1, 8 Prosperity Parade, Warriewood NSW 2102

ASX Announcement – 23 January 2026 Visionflex Group Limited (ASX:VFX)

Operational Highlights

==> picture [595 x 8] intentionally omitted <==

==> picture [155 x 23] intentionally omitted <==

• Amplar Health (Medibank): Payment received for an additional 10 Visionflex solutions, bringing the total paid to 20 of the 30 contracted deployments, following the rollout across the first 10 residential aged care facilities.

• Royal Flying Doctor Service (RFDS) Victoria : Second-year subscription renewal secured for their virtual health solution. Discussions are progressing regarding potential expansion into RFDS South Australia and other jurisdictions.

• Product & Platform: Ongoing platform enhancements continued during the quarter, supporting improved interoperability and clinical workflow efficiency. Further commercial details to be provided as initiatives mature.

Outlook

Visionflex remains focused on expanding its recurring revenue base, supported by increasing customer engagement across aged care, regional healthcare, and complex service delivery environments.

This momentum is being reinforced by the Company’s strategic focus aimed at accelerating ARR growth and deepening enterprise and government relationships.

In parallel, Visionflex continues to progress strategic partnerships designed to enhance integration, support scale, and drive broader adoption of its software platform.

Collectively, these initiatives are expected to contribute to revenue growth in H2 FY26.

-- END --

This announcement was approved for release by the Board of Directors.

For more information:

Joshua Mundey Managing Director and CEO, Visionflex Group jmundey@visionflex.com

About Visionflex Group

At Visionflex, we believe that healthcare should be accessible, efficient, and connected. Our integrated hardware and software platform allows healthcare providers to deliver comprehensive, collaborative care in real time, no matter the location. From metropolitan health networks to community-based care, Visionflex is reshaping how healthcare is delivered by connecting healthcare teams with the tools and technology needed to provide effective, efficient, and high-quality care. For more information, visit vfx-group.com.

Visionflex Group Limited ACN 138 897 533 Unit 1, 8 Prosperity Parade, Warriewood NSW 2102